Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein, Inc.    HSIC

HENRY SCHEIN, INC.

(HSIC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Henry Schein : to Present at Nasdaq's 41st Investor Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/20/2019 | 08:10am EST

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at Nasdaq’s 41st Investor Conference on Wednesday, December 4, 2019, at 8:45 a.m. GMT at The May Fair Hotel in London.

Henry Schein’s presentation can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. A replay will be available on the Henry Schein website following the presentation.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries. The Company's sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HENRY SCHEIN, INC.
01/21HENRY SCHEIN : Earns Top Marks in 2020 Corporate Equality Index for Fifth Consec..
BU
01/21HENRY SCHEIN : Ranks First in Its Industry on List of FORTUNE's 'World's Most Ad..
BU
01/13HENRY SCHEIN : Opens Disaster Relief Fund to Aid Relief Efforts in Response to A..
BU
01/08SHAREHOLDER ALERT : Robbins LLP Is Investigating Henry Schein, Inc. (HSIC) for V..
BU
2019HENRY SCHEIN INC : Regulation FD Disclosure (form 8-K)
AQ
2019HENRY SCHEIN : to Present at the 38th Annual J.P. Morgan Healthcare Conference
BU
2019HENRY SCHEIN : Celebrates 21st Annual ‘Holiday Cheer for Children' Program..
BU
2019HENRY SCHEIN : and the National Council on Disability Ally to Improve Access to ..
BU
2019HENRY SCHEIN : Chairman and CEO Stanley M. Bergman Honored for Advancing Diversi..
BU
2019SHAREHOLDER ALERT : Robbins LLP Announces Complaint Filed Against Henry Schein, ..
BU
More news
Financials (USD)
Sales 2019 9 960 M
EBIT 2019 725 M
Net income 2019 500 M
Debt 2019 1 006 M
Yield 2019 -
P/E ratio 2019 21,1x
P/E ratio 2020 19,2x
EV / Sales2019 1,14x
EV / Sales2020 1,09x
Capitalization 10 388 M
Chart HENRY SCHEIN, INC.
Duration : Period :
Henry Schein, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HENRY SCHEIN, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Average target price 69,00  $
Last Close Price 70,79  $
Spread / Highest target 13,0%
Spread / Average Target -2,53%
Spread / Lowest Target -20,9%
EPS Revisions
Managers
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Philip A. Laskaway Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN, INC.6.10%10 448
CANTEL MEDICAL CORP.-4.81%2 843
SHIP HEALTHCARE HOLDINGS, INC.1.51%2 226
PATTERSON COMPANIES14.01%2 204
MERIT MEDICAL SYSTEMS, INC.17.17%2 020
AS ONE CORPORATION1.50%1 741